Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$7.76 - $10.29 $151,320 - $200,654
-19,500 Reduced 42.39%
26,500 $266,000
Q3 2023

Oct 26, 2023

BUY
$9.14 - $24.62 $83,174 - $224,042
9,100 Added 24.66%
46,000 $431,000
Q2 2023

Jul 31, 2023

BUY
$23.2 - $27.29 $37,120 - $43,664
1,600 Added 4.53%
36,900 $905,000
Q1 2023

Aug 02, 2023

SELL
$22.26 - $30.85 $35,616 - $49,360
-1,600 Reduced 4.34%
35,300 $821,000
Q1 2023

Apr 27, 2023

BUY
$22.26 - $30.85 $22,260 - $30,850
1,000 Added 2.92%
35,300 $821,000
Q4 2022

Jan 26, 2023

SELL
$19.96 - $28.22 $185,628 - $262,446
-9,300 Reduced 21.33%
34,300 $868,000
Q3 2022

Oct 27, 2022

BUY
$18.26 - $31.1 $242,858 - $413,630
13,300 Added 43.89%
43,600 $840,000
Q2 2022

Jul 25, 2022

BUY
$19.08 - $26.7 $83,951 - $117,480
4,400 Added 16.99%
30,300 $771,000
Q1 2022

Apr 21, 2022

BUY
$21.19 - $40.01 $110,188 - $208,052
5,200 Added 25.12%
25,900 $666,000
Q4 2021

Jan 24, 2022

BUY
$30.97 - $54.03 $37,164 - $64,836
1,200 Added 6.15%
20,700 $866,000
Q3 2021

Oct 22, 2021

BUY
$34.9 - $54.54 $268,730 - $419,958
7,700 Added 65.25%
19,500 $848,000
Q4 2020

Jan 25, 2021

SELL
$25.51 - $43.38 $119,897 - $203,886
-4,700 Reduced 28.48%
11,800 $316,000
Q3 2020

Dec 14, 2020

BUY
$28.28 - $53.6 $328,048 - $621,760
11,600 Added 236.73%
16,500 $566,000
Q2 2020

Jul 23, 2020

BUY
$27.89 - $47.86 $83,670 - $143,580
3,000 Added 157.89%
4,900 $200,000
Q4 2019

Jan 24, 2020

BUY
$11.83 - $15.85 $22,477 - $30,115
1,900 New
1,900 $23,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.